Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic control

Aims The study aim was to assess the time‐related risk of developing diabetic nephropathy [albumin excretion rate (AER) ≥ 40 mg/24 h] from baseline covariates in Type 1 diabetic patients with either good or poor metabolic control (MC).

[1]  P. Andersen,et al.  The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus , 1985, Diabetologia.

[2]  H. Keen,et al.  Glycaemia, arterial pressure and micro-albuminuria in Type 1 (insulin-dependent) diabetes mellitus , 1984, Diabetologia.

[3]  A. Albert,et al.  Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. , 2001, Diabetes care.

[4]  S. Twyman,et al.  Longitudinal study of urinary albumin excretion in young diabetic patients–‐Wessex Diabetic Nephropathy Project , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[5]  S. Bandinelli,et al.  Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[6]  D. Dunger,et al.  Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes. , 2000, Diabetes care.

[7]  E. Ritz,et al.  Smoking: a factor promoting onset and progression of diabetic nephropathy. , 2000, Diabetes & metabolism.

[8]  G. Viberti,et al.  Is it possible to predict diabetic kidney disease? , 2000, Journal of endocrinological investigation.

[9]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[10]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[11]  R. Holman,et al.  United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes Mellitus , 1996, Annals of Internal Medicine.

[12]  J Ludvigsson,et al.  Declining incidence of nephropathy in insulin-dependent diabetes mellitus. , 1994, The New England journal of medicine.

[13]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[14]  P A Cleary,et al.  Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected]. , 1993, Kidney international.

[15]  J. Selby,et al.  The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control. , 1990, JAMA.

[16]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[17]  S. Kreiner,et al.  Declining Incidence of Persistent Proteinuria in Type I (Insulin-Dependent) Diabetic Patients in Denmark , 1987, Diabetes.

[18]  A. Krolewski,et al.  The changing natural history of nephropathy in type I diabetes. , 1985, The American journal of medicine.

[19]  H. Parving,et al.  Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. , 1982, Acta endocrinologica.

[20]  H. Keen,et al.  MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS , 1982, The Lancet.

[21]  M. Abbal,et al.  FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGE , 1975, The Lancet.